These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
11. [Commonly used antifungal agents in the treatment of systemic mycoses]. Berenguer Berenguer J Rev Clin Esp; 1995 Oct; 195 Suppl 3():58-65. PubMed ID: 9441308 [No Abstract] [Full Text] [Related]
12. Nephrotoxicity of amphotericin B, with emphasis on changes in tubular function. Burgess JL; Birchall R Am J Med; 1972 Jul; 53(1):77-84. PubMed ID: 4667504 [No Abstract] [Full Text] [Related]
13. Nephrotoxicity of amphotericin B, with emphasis on changes in tubular function. Burges JL; Birchall R Am J Med; 1972 Jul; 53(1):77-84. PubMed ID: 5037291 [No Abstract] [Full Text] [Related]
14. Reducing amphotericin B reactions. 3. Use of a preparation with increased phosphate buffer. Williams TW; Utz JP; Alling DW Am Rev Respir Dis; 1965 Dec; 92(6):963-5. PubMed ID: 5321054 [No Abstract] [Full Text] [Related]
15. Chemotherapy of the systemic mycoses. Utz JP Am Fam Physician; 1973 Feb; 7(2):108-14. PubMed ID: 4539760 [No Abstract] [Full Text] [Related]
16. Treatment of fungal diseases. A statement by the committee on therapy. Am Rev Respir Dis; 1969 Dec; 100(6):908-10. PubMed ID: 5357705 [No Abstract] [Full Text] [Related]
17. Drug treatment of the systemic mycoses. Newberry WM Semin Drug Treat; 1972; 2(3):313-29. PubMed ID: 4617926 [No Abstract] [Full Text] [Related]
18. Treatment of histoplasmosis and blastomycosis. Saag MS; Dismukes WE Chest; 1988 Apr; 93(4):848-51. PubMed ID: 3280262 [TBL] [Abstract][Full Text] [Related]